LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 8.12
(0.25%)
CNY 8.12
(0.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 26.03 Million CNY | 81.15% |
| 2022 | 14.36 Million CNY | -7.34% |
| 2021 | 15.5 Million CNY | -54.37% |
| 2020 | 33.98 Million CNY | 134.0% |
| 2019 | 14.52 Million CNY | -15.82% |
| 2018 | 17.25 Million CNY | -84.23% |
| 2017 | 109.38 Million CNY | 1.19% |
| 2016 | 108.1 Million CNY | 1996.76% |
| 2015 | 5.15 Million CNY | -80.17% |
| 2014 | 26 Million CNY | -79.03% |
| 2013 | 124 Million CNY | 58.97% |
| 2012 | 78 Million CNY | 0.0% |
| 2011 | 78 Million CNY | 62.5% |
| 2010 | 48 Million CNY | 0.0% |
| 2009 | 48 Million CNY | -21.31% |
| 2008 | 61 Million CNY | 24.49% |
| 2007 | 49 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 26.12 Million CNY | 0.35% |
| 2024 Q3 | 10 Million CNY | -70.68% |
| 2024 Q2 | 38.73 Million CNY | 48.27% |
| 2023 Q3 | 31.04 Million CNY | 3.18% |
| 2023 FY | 26.03 Million CNY | 81.15% |
| 2023 Q2 | 30.08 Million CNY | 113.72% |
| 2023 Q4 | 26.03 Million CNY | -16.15% |
| 2023 Q1 | 14.07 Million CNY | -2.03% |
| 2022 Q2 | 14.37 Million CNY | -3.2% |
| 2022 Q4 | 14.36 Million CNY | -0.78% |
| 2022 FY | 14.36 Million CNY | -7.34% |
| 2022 Q1 | 14.84 Million CNY | -4.26% |
| 2022 Q3 | 14.48 Million CNY | 0.77% |
| 2021 FY | 15.5 Million CNY | -54.37% |
| 2021 Q1 | 24.2 Million CNY | -28.79% |
| 2021 Q2 | 13.8 Million CNY | -42.98% |
| 2021 Q3 | 70.03 Million CNY | 407.49% |
| 2021 Q4 | 15.5 Million CNY | -77.86% |
| 2020 Q2 | 33.72 Million CNY | 41.66% |
| 2020 Q1 | 23.8 Million CNY | 63.92% |
| 2020 Q4 | 33.98 Million CNY | 0.78% |
| 2020 Q3 | 33.72 Million CNY | 0.0% |
| 2020 FY | 33.98 Million CNY | 134.0% |
| 2019 Q4 | 14.52 Million CNY | 0.0% |
| 2019 FY | 14.52 Million CNY | -15.82% |
| 2019 Q2 | 14.52 Million CNY | -96.25% |
| 2019 Q1 | 387.19 Million CNY | 2144.35% |
| 2019 Q3 | 14.52 Million CNY | 0.0% |
| 2018 Q3 | 598.31 Million CNY | 443.77% |
| 2018 Q1 | 109.71 Million CNY | 0.29% |
| 2018 FY | 17.25 Million CNY | -84.23% |
| 2018 Q4 | 17.25 Million CNY | -97.12% |
| 2018 Q2 | 110.03 Million CNY | 0.29% |
| 2017 Q3 | 109.06 Million CNY | 0.3% |
| 2017 Q4 | 109.38 Million CNY | 0.29% |
| 2017 FY | 109.38 Million CNY | 1.19% |
| 2017 Q1 | 108.42 Million CNY | 0.3% |
| 2017 Q2 | 108.74 Million CNY | 0.3% |
| 2016 Q2 | 107 Million CNY | 0.0% |
| 2016 FY | 108.1 Million CNY | 1996.76% |
| 2016 Q4 | 108.1 Million CNY | 1.03% |
| 2016 Q3 | 107 Million CNY | 0.0% |
| 2016 Q1 | 107 Million CNY | 0.0% |
| 2015 Q4 | - CNY | -100.0% |
| 2015 Q1 | 22 Million CNY | -15.38% |
| 2015 Q2 | 15 Million CNY | -31.82% |
| 2015 Q3 | 15 Million CNY | 0.0% |
| 2015 FY | 5.15 Million CNY | -80.17% |
| 2014 Q4 | 26 Million CNY | 30.0% |
| 2014 FY | 26 Million CNY | -79.03% |
| 2014 Q3 | 20 Million CNY | -33.33% |
| 2014 Q2 | 30 Million CNY | -71.15% |
| 2014 Q1 | 104 Million CNY | -16.13% |
| 2013 Q3 | 126 Million CNY | 61.54% |
| 2013 FY | 124 Million CNY | 58.97% |
| 2013 Q1 | 78 Million CNY | 0.0% |
| 2013 Q2 | 78 Million CNY | 0.0% |
| 2013 Q4 | 124 Million CNY | -1.59% |
| 2012 Q3 | 78 Million CNY | 0.0% |
| 2012 Q2 | 78 Million CNY | 0.0% |
| 2012 Q1 | 78 Million CNY | 0.0% |
| 2012 FY | 78 Million CNY | 0.0% |
| 2012 Q4 | 78 Million CNY | 0.0% |
| 2011 Q4 | 78 Million CNY | 0.0% |
| 2011 Q3 | 78 Million CNY | 6.85% |
| 2011 FY | 78 Million CNY | 62.5% |
| 2011 Q2 | 73 Million CNY | 0.0% |
| 2010 FY | 48 Million CNY | 0.0% |
| 2010 Q4 | 48 Million CNY | 0.0% |
| 2009 FY | 48 Million CNY | -21.31% |
| 2008 FY | 61 Million CNY | 24.49% |
| 2007 FY | 49 Million CNY | 0.0% |